Inclusion of Adolescents in Clinical Trials for Sexually Transmitted Infections

A Review of Existing Registered Studies

Lily F. Hoffman, Neferterneken K. Francis, Marina Catallozzi, Jenny K.R. Francis, Lawrence R. Stanberry, Susan L. Rosenthal

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Purpose: Despite their heightened risk of sexually transmitted infections, minor adolescents (<18 years old) are often excluded from clinical trials. The results of trials of adults should not be assumed to generalize to minors. Methods: Two public clinical trial registries were first searched using microbicide or PrEP with STD, STI, HIV, or HSV and with gel, ring, or film, and then searched using prevention/sexually transmitted diseases with gel. Studies were classified based on the information provided in the registry. Results: The searches yielded 111 unique studies. Only 9.0% (n = 10) included minors. They were under-represented in Phase 0-II studies and over-represented in studies of individuals infected with human immunodeficiency virus. Conclusions: Minor adolescents should be included during all stages of development and before they have acquired an infection. Future studies should examine the challenges of including minor adolescents in trials and how to overcome these barriers.

Original languageEnglish (US)
Pages (from-to)576-578
Number of pages3
JournalJournal of Adolescent Health
Volume58
Issue number5
DOIs
StatePublished - May 1 2016

Fingerprint

Sexually Transmitted Diseases
Clinical Trials
Minors
Registries
Gels
HIV
Anti-Infective Agents
Infection

Keywords

  • Adolescent
  • Clinical trials
  • Sexual health

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Public Health, Environmental and Occupational Health
  • Psychiatry and Mental health

Cite this

Inclusion of Adolescents in Clinical Trials for Sexually Transmitted Infections : A Review of Existing Registered Studies. / Hoffman, Lily F.; Francis, Neferterneken K.; Catallozzi, Marina; Francis, Jenny K.R.; Stanberry, Lawrence R.; Rosenthal, Susan L.

In: Journal of Adolescent Health, Vol. 58, No. 5, 01.05.2016, p. 576-578.

Research output: Contribution to journalArticle

Hoffman, Lily F. ; Francis, Neferterneken K. ; Catallozzi, Marina ; Francis, Jenny K.R. ; Stanberry, Lawrence R. ; Rosenthal, Susan L. / Inclusion of Adolescents in Clinical Trials for Sexually Transmitted Infections : A Review of Existing Registered Studies. In: Journal of Adolescent Health. 2016 ; Vol. 58, No. 5. pp. 576-578.
@article{873a232b6ad54e2da67e77f21dfff9e3,
title = "Inclusion of Adolescents in Clinical Trials for Sexually Transmitted Infections: A Review of Existing Registered Studies",
abstract = "Purpose: Despite their heightened risk of sexually transmitted infections, minor adolescents (<18 years old) are often excluded from clinical trials. The results of trials of adults should not be assumed to generalize to minors. Methods: Two public clinical trial registries were first searched using microbicide or PrEP with STD, STI, HIV, or HSV and with gel, ring, or film, and then searched using prevention/sexually transmitted diseases with gel. Studies were classified based on the information provided in the registry. Results: The searches yielded 111 unique studies. Only 9.0{\%} (n = 10) included minors. They were under-represented in Phase 0-II studies and over-represented in studies of individuals infected with human immunodeficiency virus. Conclusions: Minor adolescents should be included during all stages of development and before they have acquired an infection. Future studies should examine the challenges of including minor adolescents in trials and how to overcome these barriers.",
keywords = "Adolescent, Clinical trials, Sexual health",
author = "Hoffman, {Lily F.} and Francis, {Neferterneken K.} and Marina Catallozzi and Francis, {Jenny K.R.} and Stanberry, {Lawrence R.} and Rosenthal, {Susan L.}",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.jadohealth.2016.01.007",
language = "English (US)",
volume = "58",
pages = "576--578",
journal = "Journal of Adolescent Health",
issn = "1054-139X",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Inclusion of Adolescents in Clinical Trials for Sexually Transmitted Infections

T2 - A Review of Existing Registered Studies

AU - Hoffman, Lily F.

AU - Francis, Neferterneken K.

AU - Catallozzi, Marina

AU - Francis, Jenny K.R.

AU - Stanberry, Lawrence R.

AU - Rosenthal, Susan L.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Purpose: Despite their heightened risk of sexually transmitted infections, minor adolescents (<18 years old) are often excluded from clinical trials. The results of trials of adults should not be assumed to generalize to minors. Methods: Two public clinical trial registries were first searched using microbicide or PrEP with STD, STI, HIV, or HSV and with gel, ring, or film, and then searched using prevention/sexually transmitted diseases with gel. Studies were classified based on the information provided in the registry. Results: The searches yielded 111 unique studies. Only 9.0% (n = 10) included minors. They were under-represented in Phase 0-II studies and over-represented in studies of individuals infected with human immunodeficiency virus. Conclusions: Minor adolescents should be included during all stages of development and before they have acquired an infection. Future studies should examine the challenges of including minor adolescents in trials and how to overcome these barriers.

AB - Purpose: Despite their heightened risk of sexually transmitted infections, minor adolescents (<18 years old) are often excluded from clinical trials. The results of trials of adults should not be assumed to generalize to minors. Methods: Two public clinical trial registries were first searched using microbicide or PrEP with STD, STI, HIV, or HSV and with gel, ring, or film, and then searched using prevention/sexually transmitted diseases with gel. Studies were classified based on the information provided in the registry. Results: The searches yielded 111 unique studies. Only 9.0% (n = 10) included minors. They were under-represented in Phase 0-II studies and over-represented in studies of individuals infected with human immunodeficiency virus. Conclusions: Minor adolescents should be included during all stages of development and before they have acquired an infection. Future studies should examine the challenges of including minor adolescents in trials and how to overcome these barriers.

KW - Adolescent

KW - Clinical trials

KW - Sexual health

UR - http://www.scopus.com/inward/record.url?scp=84960397356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960397356&partnerID=8YFLogxK

U2 - 10.1016/j.jadohealth.2016.01.007

DO - 10.1016/j.jadohealth.2016.01.007

M3 - Article

VL - 58

SP - 576

EP - 578

JO - Journal of Adolescent Health

JF - Journal of Adolescent Health

SN - 1054-139X

IS - 5

ER -